What is Ninlaro used for?
Ninlaro (ixazomib citrate) is a proteasome inhibitor used to treat patients with multiple myleoma. Multiple myeloma is a type of cancer of the bone marrow, which occurs when plasma cells grow uncontrolled.
Ninlaro comes in the from of a capsule. The Food and Drug Administration (FDA) has specifically approved Ninlaro for use in combination with a thalidomide analog called lenalidomide (Revlimid) and dexamethasone, a corticosteroid. Ninlaro is used in multiple myleoma patients who have received at least one prior therapy.
Ninlaro works by preventing the break down of all the 'garbage' proteins that myeloma cell generate, which leads to them building up and killing the myeloma cells.
Ninlaro is made by Takeda.
References
- Food and Drug Administration (FDA). Ninlaro. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208462s006lbl.pdf. [Accessed February 4, 2021].
- Multiple Myeloma Research Foundation (MMRF). Proteasome inhibitors. April 25, 2017. Available from: https://themmrf.org/2017/04/25/proteasome-inhibitors/. [Accessed February 4, 2021].
Read next
What is CAR T-cell therapy and how does it work?
CAR T-cell therapy is a personalized treatment that uses a patient's own immune cells to fight certain cancers and autoimmune diseases. By harnessing and reprogramming a patient’s own immune cells, this therapy offers a new option for those who have not responded to conventional treatments.
Continue reading
What are CELMoD agents and how do they work?
CELMoD agents (cereblon E3 ligase modulators) are a new drug class that represents a transformative advancement in targeted protein degradation (TPD), offering novel therapeutic strategies for hematologic malignancies.
Continue reading
What are the best treatments for Multiple Myeloma?
Multiple myeloma is a cancer of plasma cells, which are white blood cells responsible for producing antibodies. While not yet curable, advancements in therapy have transformed it into a manageable condition with treatments that can achieve long-term disease control and improved quality of life. Initial treatment usually involves multi-drug combinations, such as bortezomib (a proteasome inhibitor), lenalidomide (an immunomodulatory drug), and dexamethasone (a steroid).
Continue readingSee also:
Related medical questions
- Ninlaro vs Velcade, which is better?
- How much does Ninlaro cost compared to other chemo drugs?
- Is Ninlaro (ixazomib) a chemotherapy drug? How does it work?
- Does Ninlaro cause shingles (herpes zoster)?
- How effective is Ninlaro (ixazomib)?
- Is Velcade a type of chemotherapy?
- How Does Chemotherapy Work for Multiple Myeloma?
- Can Darzalex cure Multiple Myeloma?
- Is Kyprolis a chemo drug and how does it work?
- How long does Velcade stay in your body?
- How effective is Velcade for multiple myeloma?
- Is Darzalex chemotherapy?
- What’s the difference between Tecvayli and Talvey?
- How does Tecvayli work (its mechanism of action)?
- Is Tecvayli FDA approved as a multiple myeloma treatment?
- Can Venclexta be used for Multiple Myeloma?
- Where can I find the Tecvayli FDA package insert?
- How is Kyprolis (carfilzomib) administered?
- What is the success rate for Carvykti for Multiple Myeloma?
- What is the success rate of Tecvayli?
- What should I know about the Tecvayli REMS program?
- What is Empliciti (elotuzumab)? and how does Empliciti work?
- What’s the mechanism of action of Carvykti?
- Is Abecma an orphan drug?
Drug information
- Ninlaro Information for Consumers
- Ninlaro prescribing info & package insert (for Health Professionals)
- Side Effects of Ninlaro (detailed)
- Ninlaro user reviews (3)
Related support groups
- Ninlaro (6 questions, 5 members)
- Multiple Myeloma (26 questions, 54 members)